3-(3-methylaminopropylamino)propylmercaptan has been researched along with zidovudine in 1 studies
Studies (3-(3-methylaminopropylamino)propylmercaptan) | Trials (3-(3-methylaminopropylamino)propylmercaptan) | Recent Studies (post-2010) (3-(3-methylaminopropylamino)propylmercaptan) | Studies (zidovudine) | Trials (zidovudine) | Recent Studies (post-2010) (zidovudine) |
---|---|---|---|---|---|
9 | 0 | 0 | 10,180 | 1,399 | 1,188 |
Protein | Taxonomy | 3-(3-methylaminopropylamino)propylmercaptan (IC50) | zidovudine (IC50) |
---|---|---|---|
Thymidine kinase, cytosolic | Homo sapiens (human) | 3 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.6633 | |
Protease | Human immunodeficiency virus 1 | 0.015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dale, P; Grdina, DJ; Weichselbaum, R | 1 |
1 other study(ies) available for 3-(3-methylaminopropylamino)propylmercaptan and zidovudine
Article | Year |
---|---|
Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326.
Topics: Humans; Hypoxanthine Phosphoribosyltransferase; In Vitro Techniques; Mutagenesis; Radiation-Protective Agents; Sulfhydryl Compounds; Tumor Cells, Cultured; Zidovudine | 1992 |